1
|
|
2
|
van Vugt L, van den Reek J, Meulewaeter E, Hakobjan M, Heddes N, Traks T, Kingo K, Galluzzo M, Talamonti M, Lambert J, Coenen M, de Jong E. Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts. J Eur Acad Dermatol Venereol 2020; 34:112-118. [PMID: 31287604 PMCID: PMC7004147 DOI: 10.1111/jdv.15787] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2019] [Accepted: 06/27/2019] [Indexed: 12/12/2022]
Abstract
BACKGROUND Genetic predictors for treatment response could optimize allocation of biological treatment in patients with psoriasis. There is minimal knowledge about pharmacogenetics of anti-IL-17 agents. OBJECTIVES To assess whether genetic variants in the protein-coding region or untranslated regions of the IL-17A gene are associated with response to IL-17A inhibitors in patients with psoriasis. METHODS This was a multicenter European cohort study investigating pharmacogenetics of IL-17A inhibitors in patients with psoriasis. Patients with plaque psoriasis treated with secukinumab or ixekizumab in daily practice were included. For all participants, the protein-coding region and untranslated regions of the IL-17A gene were analysed using Sanger sequencing. Identified genetic variants were tested for association with response to secukinumab/ixekizumab, measured as ∆PASI, after 12 weeks (primary outcome) and after 24 weeks (secondary outcome). Association was tested using a linear regression model with correction for baseline PASI as a fixed covariate and for biological naivety and body mass index as additional covariates. RESULTS In total, 134 patients treated with secukinumab or ixekizumab were included. Genotyping of the cohort identified genetic variants present in untranslated regions and intronic DNA, but not in the protein-coding region of the IL-17A gene. Five genetic variants in non-coding DNA with a known or suspected functional effect on IL-17A expression were selected for association analyses: rs2275913, rs8193037, rs3819025, rs7747909 and rs3748067. After 12 weeks, 62% of patients achieved PASI75 and 39% achieved PASI90. At week 24, PASI75 and PASI90 response rates were 72% and 62%, respectively. No associations were found between the five genetic variants and ∆PASI, PASI75 or PASI90 after 12 and 24 weeks of anti-IL-17A treatment. CONCLUSIONS Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene. Pharmacogenetics of IL-17A inhibitors in the treatment of psoriasis requires further exploration.
Collapse
Affiliation(s)
- L.J. van Vugt
- Department of DermatologyRadboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
- Radboud Institute for Health Sciences (RIHS)Radboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
| | - J.M.P.A. van den Reek
- Department of DermatologyRadboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
- Radboud Institute for Health Sciences (RIHS)Radboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
| | - E. Meulewaeter
- Department of DermatologyGhent University HospitalGhentBelgium
| | - M. Hakobjan
- Department of Human GeneticsRadboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
| | - N. Heddes
- Department of DermatologyRadboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
| | - T. Traks
- Department of DermatologyUniversity of TartuTartuEstonia
- Department of DermatologyTartu University HospitalTartuEstonia
| | - K. Kingo
- Department of DermatologyUniversity of TartuTartuEstonia
- Department of DermatologyTartu University HospitalTartuEstonia
| | - M. Galluzzo
- Department of DermatologyUniversity of Rome Tor VergataRomeItaly
| | - M. Talamonti
- Department of DermatologyUniversity of Rome Tor VergataRomeItaly
| | - J. Lambert
- Department of DermatologyGhent University HospitalGhentBelgium
| | - M.J.H. Coenen
- Radboud Institute for Health Sciences (RIHS)Radboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
- Department of Human GeneticsRadboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
| | - E.M.G.J. de Jong
- Department of DermatologyRadboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
- Radboud Institute for Health Sciences (RIHS)Radboud University Medical Centre (Radboudumc)NijmegenThe Netherlands
- Radboud UniversityNijmegenThe Netherlands
| |
Collapse
|
3
|
Logger J, de Vries FC, van Erp PJ, de Jong E, Peppelman M, Driessen R. 评估酒渣鼻的不同方法回顾. Br J Dermatol 2020. [DOI: 10.1111/bjd.18681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
4
|
Mertens J, de Jong E, van den Hoogen L, Wienke J, Thurlings R, Seyger M, Hoppenreijs E, Wijngaarde C, van Vlijmen-Willems I, van den Bogaard E, Giovannone B, van Wijk F, van Royen-Kerkhof A, Marut W, Radstake T. The identification of CCL18 as biomarker of disease activity in localized scleroderma. J Autoimmun 2019; 101:86-93. [DOI: 10.1016/j.jaut.2019.04.008] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2019] [Revised: 04/06/2019] [Accepted: 04/08/2019] [Indexed: 01/10/2023]
|
5
|
Klijn S, van den Reek J, van de Wetering G, van der Kolk A, de Jong E, Kievit W. Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE. Br J Dermatol 2018. [DOI: 10.1111/bjd.16613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Klijn S, van den Reek J, van de Wetering G, van der Kolk A, de Jong E, Kievit W. 斑块状银屑病的生物治疗顺序:基于来自BioCAPTURE的10年荷兰实际证据的成本效用分析. Br J Dermatol 2018. [DOI: 10.1111/bjd.16632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
Klijn S, van den Reek J, van de Wetering G, van der Kolk A, de Jong E, Kievit W. Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE. Br J Dermatol 2018; 178:1181-1189. [DOI: 10.1111/bjd.16247] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/01/2017] [Indexed: 12/16/2022]
Affiliation(s)
- S.L. Klijn
- Pharmerit International; Health Economics and Outcomes Research; Rotterdam the Netherlands
| | | | - G. van de Wetering
- Pharmerit International; Health Economics and Outcomes Research; Rotterdam the Netherlands
| | | | - E.M.G.J. de Jong
- Department of Dermatology; Radboud UMC; Nijmegen the Netherlands
| | - W. Kievit
- Radboud Institute for Health Sciences; Radboud UMC; Nijmegen the Netherlands
| |
Collapse
|
8
|
Vugt L, van den Reek J, Coenen M, de Jong E. 有关生物制剂对银屑病患者的疗效的药物遗传学研究:系统综述. Br J Dermatol 2018. [DOI: 10.1111/bjd.16201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
van Vugt L, van den Reek J, Coenen M, de Jong E. A systematic review of pharmacogenetic studies on the response to biologics in patients with psoriasis. Br J Dermatol 2018. [DOI: 10.1111/bjd.16197] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
van den Reek J, Seyger M, van Lümig P, Driessen R, Schalkwijk C, Berends M, van de Kerkhof P, de Jong E. The journey of adult psoriasis patients towards biologics: past and present - Results from the BioCAPTURE registry. J Eur Acad Dermatol Venereol 2017; 32:615-623. [DOI: 10.1111/jdv.14684] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2017] [Accepted: 10/20/2017] [Indexed: 02/06/2023]
Affiliation(s)
| | - M.M.B. Seyger
- Department of Dermatology; Radboudumc; Nijmegen The Netherlands
| | | | - R.J.B. Driessen
- Department of Dermatology; Radboudumc; Nijmegen The Netherlands
| | | | - M.A.M. Berends
- Department of Dermatology; Slingeland Hospital; Doetinchem The Netherlands
| | | | - E.M.G.J. de Jong
- Department of Dermatology; Radboudumc; Nijmegen The Netherlands
- Radboud University; Nijmegen The Netherlands
| |
Collapse
|
11
|
van den Reek J, Kievit W, de Jong E. Comment on “Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis”. Actas Dermo-Sifiliográficas 2017; 108:695-696. [DOI: 10.1016/j.ad.2017.03.012] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2017] [Accepted: 03/10/2017] [Indexed: 11/24/2022] Open
|
12
|
van den Reek J, Kievit W, de Jong E. Comment on “Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis”. Actas Dermo-Sifiliográficas (English Edition) 2017. [DOI: 10.1016/j.adengl.2017.03.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
13
|
Reich K, Zschocke I, Bachelez H, de Jong E, Gisondi P, Puig L, Warren R, Ortland C, Mrowietz U. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP). Br J Dermatol 2017; 177:197-205. [DOI: 10.1111/bjd.15466] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/08/2017] [Indexed: 11/28/2022]
Affiliation(s)
- K. Reich
- Dermatologikum Hamburg; Hamburg Germany
- SCIderm GmbH; Hamburg Germany
| | | | - H. Bachelez
- Sorbonne Paris Cité Université Paris-Diderot; AP-HP Hôpital Saint-Louis; Paris France
| | - E.M.G.J. de Jong
- Radboud University Medical Centre and Radboud University; Nijmegen the Netherlands
| | - P. Gisondi
- Dermatology and Venerology Section; University of Verona; Verona Italy
| | - L. Puig
- Department of Dermatology; Hospital de la Santa Creu i Sant Pau; Universitat Autònoma de Barcelona; Barcelona Spain
| | - R.B. Warren
- The Dermatology Centre; Salford Royal NHS Foundation Trust; The University of Manchester; Manchester Academic Health Science Centre; Manchester U.K
| | - C. Ortland
- Das Forschungsdock Service for Clinical Development; Schenefeld Germany
| | - U. Mrowietz
- Psoriasis Center; Department of Dermatology; University Medical Center Schleswig-Holstein; Campus Kiel; Kiel Germany
| | | |
Collapse
|
14
|
van den Reek J, Coenen M, van de L'Isle Arias M, Zweegers J, Rodijk-Olthuis D, Schalkwijk J, Vermeulen S, Joosten I, van de Kerkhof P, Seyger M, Zeeuwen P, de Jong E. Polymorphisms inCD84,IL12BandTNFAIP3are associated with response to biologics in patients with psoriasis. Br J Dermatol 2017; 176:1288-1296. [DOI: 10.1111/bjd.15005] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/20/2016] [Indexed: 12/11/2022]
Affiliation(s)
- J.M.P.A. van den Reek
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - M.J.H. Coenen
- Department of Human Genetics; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - M. van de L'Isle Arias
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - J. Zweegers
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - D. Rodijk-Olthuis
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - J. Schalkwijk
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - S.H. Vermeulen
- Department of Health Evidence; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - I. Joosten
- Department of Immunology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - M.M.B. Seyger
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - P.L.J.M. Zeeuwen
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; Radboud Institutes for Molecular Life Sciences (RIMLS) and Health Sciences (RIHS); Nijmegen the Netherlands
| |
Collapse
|
15
|
Zweegers J, Groenewoud J, van den Reek J, Otero M, van de Kerkhof P, Driessen R, van Lümig P, Njoo M, Ossenkoppele P, Mommers J, Koetsier M, Arnold W, Andriessen M, Kuijpers A, Berends M, Kievit W, de Jong E. Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry. Br J Dermatol 2017; 176:1001-1009. [DOI: 10.1111/bjd.15023] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/20/2016] [Indexed: 01/24/2023]
Affiliation(s)
- J. Zweegers
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - J.M.M. Groenewoud
- Radboud University Medical Center; Radboud Institute for Health Sciences; Nijmegen the Netherlands
| | - J.M.P.A. van den Reek
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - M.E. Otero
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - R.J.B. Driessen
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - P.P.M. van Lümig
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - M.D. Njoo
- Department of Dermatology; Ziekenhuisgroep Twente; Almelo/Hengelo the Netherlands
| | - P.M. Ossenkoppele
- Department of Dermatology; Ziekenhuisgroep Twente; Almelo/Hengelo the Netherlands
| | - J.M. Mommers
- Department of Dermatology; St Anna Ziekenhuis; Geldrop the Netherlands
| | - M.I.A. Koetsier
- Department of Dermatology; Gelre Ziekenhuizen; Apeldoorn the Netherlands
| | - W.P. Arnold
- Department of Dermatology; Ziekenhuis Gelderse Vallei; Ede the Netherlands
| | - M.P.M. Andriessen
- Department of Dermatology; Jeroen Bosch Ziekenhuis; Den Bosch the Netherlands
| | - A.L.A. Kuijpers
- Department of Dermatology; Maxima Medisch Centrum; Eindhoven/Veldhoven the Netherlands
| | - M.A.M. Berends
- Department of Dermatology; Slingeland Ziekenhuis; Doetinchem the Netherlands
| | - W. Kievit
- Radboud University Medical Center; Radboud Institute for Health Sciences; Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| |
Collapse
|
16
|
van Beugen S, van Middendorp H, Ferwerda M, Smit J, Zeeuwen-Franssen M, Kroft E, de Jong E, Donders A, van de Kerkhof P, Evers A. Predictors of perceived stigmatization in patients with psoriasis. Br J Dermatol 2016; 176:687-694. [DOI: 10.1111/bjd.14875] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/23/2016] [Indexed: 12/22/2022]
Affiliation(s)
- S. van Beugen
- Institute of Psychology, Health, Medical and Neuropsychology Unit; Leiden University; Leiden the Netherlands
- Department of Medical Psychology; Radboud University Medical Center; Nijmegen the Netherlands
| | - H. van Middendorp
- Institute of Psychology, Health, Medical and Neuropsychology Unit; Leiden University; Leiden the Netherlands
- Department of Medical Psychology; Radboud University Medical Center; Nijmegen the Netherlands
| | - M. Ferwerda
- Institute of Psychology, Health, Medical and Neuropsychology Unit; Leiden University; Leiden the Netherlands
- Department of Medical Psychology; Radboud University Medical Center; Nijmegen the Netherlands
| | - J.V. Smit
- Department of Dermatology; Rijnstate Hospital; Velp the Netherlands
| | | | - E.B.M. Kroft
- Department of Dermatology; Ziekenhuisgroep Twente; Almelo the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - A.R.T. Donders
- Department for Health Evidence; Radboud University Medical Center; Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - A.W.M. Evers
- Institute of Psychology, Health, Medical and Neuropsychology Unit; Leiden University; Leiden the Netherlands
- Department of Medical Psychology; Radboud University Medical Center; Nijmegen the Netherlands
| |
Collapse
|
17
|
van Geel M, Otero M, de Jong E, van de Kerkhof P, Seyger M. Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis. Br J Dermatol 2016; 176:771-776. [DOI: 10.1111/bjd.15120] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/20/2016] [Indexed: 02/02/2023]
Affiliation(s)
- M.J. van Geel
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - M.E. Otero
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - M.M.B. Seyger
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| |
Collapse
|
18
|
Zweegers J, Roosenboom B, van de Kerkhof P, van den Reek J, Otero M, Atalay S, Kuijpers A, Koetsier M, Arnold W, Berends M, Weppner-Parren L, Bijen M, Njoo M, Mommers J, van Lümig P, Driessen R, Kievit W, de Jong E. Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort. Br J Dermatol 2016; 176:786-793. [DOI: 10.1111/bjd.14888] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/15/2016] [Indexed: 01/24/2023]
Affiliation(s)
- J. Zweegers
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - B. Roosenboom
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - J.M.P.A. van den Reek
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - M.E. Otero
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - S. Atalay
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | | | | | - W.P. Arnold
- Ziekenhuis Gelderse Vallei; Ede the Netherlands
| | - M.A. Berends
- Slingeland Ziekenhuis; Doetinchem the Netherlands
| | | | - M. Bijen
- Ziekenhuisgroep Twente; Almelo/Hengelo the Netherlands
| | - M.D. Njoo
- Ziekenhuisgroep Twente; Almelo/Hengelo the Netherlands
| | | | - P.P.M. van Lümig
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - R.J.B. Driessen
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
| | - W. Kievit
- Department of Epidemiology, Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands
- Radboud University Nijmegen; Nijmegen the Netherlands
| |
Collapse
|
19
|
Zweegers J, van den Reek J, van de Kerkhof P, Otero M, Kuijpers A, Koetsier M, Arnold W, Berends M, Weppner-Parren L, Ossenkoppele P, Njoo M, Mommers J, van Lümig P, Driessen R, Kievit W, de Jong E. Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t. Br J Dermatol 2016; 175:340-7. [DOI: 10.1111/bjd.14552] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/19/2016] [Indexed: 12/27/2022]
Affiliation(s)
- J. Zweegers
- Department of Dermatology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | - J.M.P.A. van den Reek
- Department of Dermatology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | - M.E. Otero
- Department of Dermatology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | | | | | - W.P. Arnold
- Ziekenhuis Gelderse Vallei; Ede the Netherlands
| | | | | | | | - M.D. Njoo
- Ziekenhuisgroep Twente; Almelo Hengelo the Netherlands
| | | | - P.P.M. van Lümig
- Department of Dermatology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | - R.J.B. Driessen
- Department of Dermatology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | - W. Kievit
- Department of Epidemiology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen the Netherlands
- Radboud University; Nijmegen the Netherlands
| |
Collapse
|
20
|
Politiek K, van der Schaft J, Christoffers W, Coenraads P, van den Reek J, de Jong E, de Bruin-Weller M, Schuttelaar M. Drug survival of methotrexate treatment in hand eczema patients: results from a retrospective daily practice study. J Eur Acad Dermatol Venereol 2015; 30:1405-7. [DOI: 10.1111/jdv.13253] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- K. Politiek
- Department of Dermatology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands
| | - J. van der Schaft
- Department of Dermatology & Allergology; University Medical Centre Utrecht; Utrecht The Netherlands
| | - W.A. Christoffers
- Department of Dermatology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands
| | - P.J. Coenraads
- Department of Dermatology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands
| | - J.M.P.A. van den Reek
- Department of Dermatology; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands
| | - M.S. de Bruin-Weller
- Department of Dermatology & Allergology; University Medical Centre Utrecht; Utrecht The Netherlands
| | - M.L.A. Schuttelaar
- Department of Dermatology; University of Groningen; University Medical Center Groningen; Groningen The Netherlands
| |
Collapse
|
21
|
Hopman J, Maat I, Jong ED, Liem D, Boode WD, Voss A, Tostmann A. Risk factors for enterobacter cloacae colonisation at a neonatal intensive care unit in the Netherlands. Antimicrob Resist Infect Control 2015. [PMCID: PMC4475099 DOI: 10.1186/2047-2994-4-s1-p237] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
22
|
van der Schaft J, Politiek K, van den Reek J, Christoffers W, Kievit W, de Jong E, Bruijnzeel-Koomen C, Schuttelaar M, de Bruin-Weller M. Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis. Br J Dermatol 2015; 172:1621-1627. [DOI: 10.1111/bjd.13730] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/04/2015] [Indexed: 01/05/2023]
Affiliation(s)
- J. van der Schaft
- Department of Dermatology and Allergology; University Medical Center Utrecht; Utrecht the Netherlands
| | - K. Politiek
- Department of Dermatology; University Medical Center Groningen; Groningen the Netherlands
| | - J.M.P.A. van den Reek
- Department of Dermatology; Radboud University Nijmegen Medical Centre; Nijmegen the Netherlands
| | - W.A. Christoffers
- Department of Dermatology; University Medical Center Groningen; Groningen the Netherlands
| | - W. Kievit
- Department of Health Evidence; Radboud University Nijmegen Medical Centre; Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Nijmegen Medical Centre; Nijmegen the Netherlands
| | | | - M.L.A. Schuttelaar
- Department of Dermatology; University Medical Center Groningen; Groningen the Netherlands
| | - M.S. de Bruin-Weller
- Department of Dermatology and Allergology; University Medical Center Utrecht; Utrecht the Netherlands
| |
Collapse
|
23
|
Mertens J, Seyger M, Kievit W, Hoppenreijs E, Jansen T, van de Kerkhof P, Radstake T, de Jong E. Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease. Br J Dermatol 2015; 172:722-8. [DOI: 10.1111/bjd.13514] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/02/2014] [Indexed: 01/25/2023]
Affiliation(s)
- J.S. Mertens
- Department of Dermatology; Radboud University Medical Center; Nijmegen The Netherlands
| | - M.M.B. Seyger
- Department of Dermatology; Radboud University Medical Center; Nijmegen The Netherlands
| | - W. Kievit
- Department of Epidemiology, Biostatistics and Health Technology Assessment; Radboud University Medical Center; Nijmegen The Netherlands
| | - E.P.A.H. Hoppenreijs
- Department of Pediatric Rheumatology; Radboud University Medical Center; Nijmegen The Netherlands
| | - T.L.Th.A. Jansen
- Department of Rheumatology; Radboud University Medical Center; Nijmegen The Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; Nijmegen The Netherlands
| | - T.R.D. Radstake
- Department of Rheumatology and Clinical Immunology and Laboratory of Translational Immunology; University Medical Center Utrecht; Utrecht The Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; Nijmegen The Netherlands
| |
Collapse
|
24
|
van Geel M, Mul K, de Jager M, van de Kerkhof P, de Jong E, Seyger M. Systemic treatments in paediatric psoriasis: a systematic evidence-based update. J Eur Acad Dermatol Venereol 2014; 29:425-37. [DOI: 10.1111/jdv.12749] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2014] [Accepted: 08/13/2014] [Indexed: 01/12/2023]
Affiliation(s)
- M.J. van Geel
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - K. Mul
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - M.E.A. de Jager
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - M.M.B. Seyger
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| |
Collapse
|
25
|
Oostveen A, de Jong E, Donders A, van de Kerkhof P, Seyger M. Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice. J Eur Acad Dermatol Venereol 2014; 29:1193-7. [DOI: 10.1111/jdv.12789] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2014] [Accepted: 09/19/2014] [Indexed: 01/27/2023]
Affiliation(s)
- A.M. Oostveen
- Department of Dermatology; Radboud university medical center; Nijmegen The Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud university medical center; Nijmegen The Netherlands
| | - A.R.T. Donders
- Department for Health Evidence; Radboud university medical center; Nijmegen The Netherlands
| | - P.C.M. van de Kerkhof
- Department for Health Evidence; Radboud university medical center; Nijmegen The Netherlands
| | - M.M.B. Seyger
- Department for Health Evidence; Radboud university medical center; Nijmegen The Netherlands
| |
Collapse
|
26
|
van den Reek J, Tummers M, Zweegers J, Seyger M, van Lümig P, Driessen R, van de Kerkhof P, Kievit W, de Jong E. Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry. J Eur Acad Dermatol Venereol 2014; 29:560-5. [DOI: 10.1111/jdv.12636] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2014] [Accepted: 07/10/2014] [Indexed: 01/13/2023]
Affiliation(s)
- J.M.P.A. van den Reek
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - M. Tummers
- Department for Health Evidence; Radboud university medical center; Nijmegen the Netherlands
| | - J. Zweegers
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - M.M.B. Seyger
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - P.P.M. van Lümig
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - R.J.B. Driessen
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| | - W. Kievit
- Department for Health Evidence; Radboud university medical center; Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud university medical center; Nijmegen the Netherlands
| |
Collapse
|
27
|
van Geel M, Mul K, Oostveen A, van de Kerkhof P, de Jong E, Seyger M. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort. Br J Dermatol 2014; 171:363-9. [DOI: 10.1111/bjd.12895] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/08/2014] [Indexed: 11/29/2022]
Affiliation(s)
- M.J. van Geel
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen The Netherlands
| | - K. Mul
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen The Netherlands
| | - A.M. Oostveen
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen The Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen The Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen The Netherlands
| | - M.M.B. Seyger
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen The Netherlands
| |
Collapse
|
28
|
de Brouwer S, van Middendorp H, Stormink C, Kraaimaat F, Sweep F, de Jong E, Schalkwijk J, Eijsbouts A, Donders A, van de Kerkhof P, van Riel P, Evers A. The psychophysiological stress response in psoriasis and rheumatoid arthritis. Br J Dermatol 2014; 170:824-31. [DOI: 10.1111/bjd.12697] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/17/2013] [Indexed: 02/01/2023]
Affiliation(s)
- S.J.M. de Brouwer
- Department of Medical Psychology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
- Institute of Psychology, Health, Medical and Neuropsychology Unit; Leiden University; P.O. Box 9555 2300 RB Leiden the Netherlands
| | - H. van Middendorp
- Department of Medical Psychology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
- Institute of Psychology, Health, Medical and Neuropsychology Unit; Leiden University; P.O. Box 9555 2300 RB Leiden the Netherlands
| | - C. Stormink
- Department of Medical Psychology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - F.W. Kraaimaat
- Department of Medical Psychology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - F.C.G.J. Sweep
- Department of Laboratory Medicine; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - J. Schalkwijk
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - A. Eijsbouts
- Department of Rheumatology; Sint Maartenskliniek; P.O. Box 9011 6500 GM Nijmegen the Netherlands
| | - A.R.T. Donders
- Department for Health Evidence; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - P.L.C.M. van Riel
- Department of Rheumatology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
| | - A.W.M. Evers
- Department of Medical Psychology; Radboud University Medical Center; P.O. Box 9101 6500 HB Nijmegen the Netherlands
- Institute of Psychology, Health, Medical and Neuropsychology Unit; Leiden University; P.O. Box 9555 2300 RB Leiden the Netherlands
| |
Collapse
|
29
|
Hendriks A, van der Velden H, Wolberink E, Seyger M, Schalkwijk J, Zeeuwen P, de Jong E, Pasch M, van Erp P, van de Kerkhof P. The effect of adalimumab on key drivers in the pathogenesis of psoriasis. Br J Dermatol 2014; 170:571-80. [DOI: 10.1111/bjd.12705] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/23/2013] [Indexed: 10/26/2022]
Affiliation(s)
- A.G.M. Hendriks
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - H.M.J. van der Velden
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - E.A.W. Wolberink
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - M.M.B. Seyger
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - J. Schalkwijk
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - P.L.J.M. Zeeuwen
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - E.M.G.J. de Jong
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - M.C. Pasch
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - P.E.J. van Erp
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| | - P.C.M. van de Kerkhof
- Department of Dermatology; Radboud University Medical Center; PO Box 9101 6500 HB Nijmegen the Netherlands
| |
Collapse
|
30
|
Zweegers J, de Jong E, Nijsten T, de Bes J, te Booij M, Borgonjen R, van Cranenburgh O, van Deutekom H, van Everdingen J, de Groot M, van Hees C, Hulshuizen H, Koek M, de Korte W, de Korte J, Lecluse L, Pasch M, Poblete-Gutierrez P, Prens E, Seyger M, Thio H, Torcque L, de Vries A, van de Kerkhof P, Spuls P. Summary of the Dutch S3-Guidelines on the treatment of psoriasis 2011. Dermatol Online J 2014. [DOI: 10.5070/d3203021769] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
31
|
Hendriks A, Keijsers R, de Jong E, Seyger M, van de Kerkhof P. Efficacy and safety of combinations of first-line
topical treatments in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 27:931-51. [DOI: 10.1111/jdv.12058] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
van den Reek J, van Lümig P, Janssen M, Schers H, Hendriks J, van de Kerkhof P, Seyger M, de Jong E. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases. J Eur Acad Dermatol Venereol 2012; 28:27-33. [DOI: 10.1111/jdv.12041] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
33
|
Oostveen A, de Jager M, van de Kerkhof P, Donders A, de Jong E, Seyger M. The influence of treatments in daily clinical practice on the Children’s Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry. Br J Dermatol 2012; 167:145-9. [DOI: 10.1111/j.1365-2133.2012.10996.x] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
van Lümig P, van de Kerkhof P, Boezeman J, Driessen R, de Jong E. Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients. J Eur Acad Dermatol Venereol 2012; 27:593-600. [DOI: 10.1111/j.1468-3083.2012.04496.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
35
|
van Lümig P, Driessen R, Roelofs-Thijssen M, Boezeman J, van de Kerkhof P, de Jong E. Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab. Br J Dermatol 2011; 165:375-82. [DOI: 10.1111/j.1365-2133.2011.10329.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
36
|
van Lümig P, Driessen R, Berends M, Boezeman J, van de Kerkhof P, de Jong E. Safety of treatment with biologics for psoriasis in daily practice: 5-year data. J Eur Acad Dermatol Venereol 2011; 26:283-91. [DOI: 10.1111/j.1468-3083.2011.04044.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
de Jager M, de Jong E, van de Kerkhof P, Evers A, Seyger M. An intrapatient comparison of quality of life in psoriasis in childhood and adulthood. J Eur Acad Dermatol Venereol 2010; 25:828-31. [DOI: 10.1111/j.1468-3083.2010.03872.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
38
|
Verhoeven E, Kraaimaat F, de Jong E, Schalkwijk J, van de Kerkhof P, Evers A. Individual differences in the effect of daily stressors on psoriasis: a prospective study. Br J Dermatol 2009; 161:295-9. [DOI: 10.1111/j.1365-2133.2009.09194.x] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
39
|
Driessen R, de Jong E, de Rie M, Salemink G, van de Kerkhof P. Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis. Br J Dermatol 2008; 159:760-1. [DOI: 10.1111/j.1365-2133.2008.08729.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
40
|
van Lingen R, Körver J, van de Kerkhof P, Berends M, van Rens D, Langewouters A, Boezeman J, Seyger M, de Jong E. Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies. Br J Dermatol 2008; 159:91-6. [DOI: 10.1111/j.1365-2133.2008.08618.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
van Lingen R, van de Kerkhof P, Seyger M, de Jong E, van Rens D, Poll M, Zeeuwen P, van Erp P. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes. Br J Dermatol 2008; 158:1264-72. [DOI: 10.1111/j.1365-2133.2008.08515.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
42
|
Vissers W, van Vlijmen I, van Erp P, de Jong E, van de Kerkhof P. Topical treatment of mild to moderate plaque psoriasis with 0·3% tacrolimus gel and 0·5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. Br J Dermatol 2008; 158:705-12. [DOI: 10.1111/j.1365-2133.2008.08442.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|